Radioactive isotopes (or radioisotopes) have been employed for cancer treatment for years, with radioactive iodine being used to treat tumours of the thyroid gland since the 1950s. However, the vast ...

The CERN-MEDICIS facility in Geneva, Switzerland has produced radioisotopes for medical research for the first time. This is the first step in the MEDICIS facility’s plans to make a large number of ...

WEST VALLEY CITY, Utah, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of radioisotopes, today cut the ribbon on its 190,000-square-foot radioisotope ...

NorthStar Medical Radioisotopes, LLC formerly of Madison, Wisconsin now headquartered in Beloit, is the recipient of a $15 million cooperative agreement award from the U.S. Department of Energy’s ...

Along with the development of 18F- and 68Ga-labeled PET agents, radioisotopes have enabled precise diagnostic imaging across diverse clinical applications. Similarly, radiotherapy, a long-established ...

Using its electron linear accelerator, researchers have enabled two companies to demonstrate new methods for the production of molybdenum-99, the parent isotope of technetium-99m – a medical isotope ...

Collaboration expands August 2023 agreement under which NorthStar’s environmentally preferable, high purity n.c.a. Ac-225 will be used in Curadh’s molecularly targeted radiation (MTR) programs for ...

Scalable generator-based supply model capable of supporting global customers from first-in-human trials through commercial clinical supply BELOIT, Wis., January 06, 2026--(BUSINESS WIRE)--NorthStar ...

There are few people in this world who make their living producing radioactive substances. These isotope producers constitute a small exclusive group of experts in this very specialized area. One ...

Fifty-one participants from 16 countries in Asia and the Pacific took part in an IAEA-organized tutor-guided, e-learning course on diagnostic and therapeutic radioisotopes and radiopharmaceuticals ...

The Rads to Watts contract is the latest sign of support for Avalanche's approach to modular fusion technology. The company announced a $29M funding round in early February 2026, as well as a $1.25M ...